111

SCHOTT PHARMA AG & CO. KGAA

No trades
See on Supercharts

1SXP fundamentals

SCHOTT PHARMA AG & CO. KGAA financial statements, including revenue, expenses, profit, and loss

The total revenue of 1SXP for the last quarter is 253.59 M EUR, and it's 8.28% higher compared to the previous quarter. The net income of Q3 24 is 46.26 M EUR.

Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: EUR
Q4 '22
Q1 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth